BioGaia AB (BIOG B):企業の財務・戦略的SWOT分析

◆英語タイトル:BioGaia AB (BIOG B) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1352
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

BioGaia AB (BIOG B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioGaia AB (BioGaia) is a biopharmaceutical company, which develops, markets and sells probiotic products. The company sells its probiotic food supplements and oral health products in various dosage forms including drops, lozenges, tablets, chewable tablets, oral rehydration salts (ORS), straws and infant formulas. BioGaia’s products are based on various strains of Lactobacillus reuteri, its patented lactic acid bacterium. Its products improve the digestive and oral health of children and adults, and controls digestive problems such as colic, regurgitation, diarrhea and constipation. The company’ sells its products through distributors in the Americas, Europe and Asia-Pacific. BioGaia is headquartered in Stockholm, Sweden.

BioGaia AB Key Recent Developments

Mar 30,2020: BioGaia update concerning COVID-19 pandemic
Feb 11,2020: BioGaia’s oral health probiotic L. reuteri Prodentis reduces bleeding of the gums
Feb 06,2020: BioGaia – Year-end report 2019
Oct 23,2019: BioGaia interim management statement 1 January – 30 September 2019
Oct 10,2019: BioGaia: Reduced sales due to delivery delays

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioGaia AB – Key Facts
BioGaia AB – Key Employees
BioGaia AB – Key Employee Biographies
BioGaia AB – Major Products and Services
BioGaia AB – History
BioGaia AB – Company Statement
BioGaia AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioGaia AB – Business Description
Business Segment: Adult Health
Overview
Performance
Business Segment: Other
Overview
Performance
Business Segment: Pediatric
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: EMEA
Performance
BioGaia AB – SWOT Analysis
SWOT Analysis – Overview
BioGaia AB – Strengths
BioGaia AB – Weaknesses
BioGaia AB – Opportunities
BioGaia AB – Threats
BioGaia AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
BioGaia AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 30, 2020: BioGaia update concerning COVID-19 pandemic
Feb 06, 2020: BioGaia – Year-end report 2019
Oct 23, 2019: BioGaia interim management statement 1 January – 30 September 2019
Oct 10, 2019: BioGaia: Reduced sales due to delivery delays
Aug 08, 2019: BioGaia Interim report 1 January – 30 June 2019
Mar 18, 2019: Finland first market to launch BioGaia Protectis capsules
Feb 07, 2019: BioGaia– Year-end report 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioGaia AB, Key Facts
BioGaia AB, Key Employees
BioGaia AB, Key Employee Biographies
BioGaia AB, Major Products and Services
BioGaia AB, History
BioGaia AB, Other Locations
BioGaia AB, Subsidiaries
BioGaia AB, Key Competitors
BioGaia AB, Ratios based on current share price
BioGaia AB, Annual Ratios
BioGaia AB, Annual Ratios (Cont...1)
BioGaia AB, Annual Ratios (Cont...2)
BioGaia AB, Interim Ratios
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
BioGaia AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
BioGaia AB, Performance Chart (2015 - 2019)
BioGaia AB, Ratio Charts
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioGaia AB, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[BioGaia AB (BIOG B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LG Chem Ltd (051910):電力:M&Aディール及び事業提携情報
    Summary LG Chem Ltd (LG Chem) is a chemical manufacturer. It manufactures and markets petrochemicals, IT and electronic materials, and energy solutions. The company’s product portfolio comprises poly vinyl chloride (PVC), ethylene, propylene, butadiene, benzene, polarizer, glass substrate, semicondu …
  • Maersk Drilling AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Maersk Drilling A/S (Maersk) formerly Maersk Contractors, a subsidiary of A.P. Moller - Maersk A/S, is an oil and gas company that offers drilling services. The company operates a fleet of drilling barges such as smaller rigs optimized for shallow water drilling and operated on management co …
  • Navitas Limited (NVT):企業の財務・戦略的SWOT分析
    Navitas Limited (NVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CooperSurgical Inc:企業のM&A・事業提携・投資動向
    CooperSurgical Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CooperSurgical Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Aequus Pharmaceuticals Inc (AQS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • Elia System Operator SA (ELI):電力:M&Aディール及び事業提携情報
    Summary Elia System Operator SA (Elia) is a transmission system operator. It owns and operates high-voltage electricity transmission systems in Belgium and Germany. The company transmits electricity from generators to distribution system operators and industrial consumers. Elia also imports and expo …
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kimco Realty Corp (KIM):企業の財務・戦略的SWOT分析
    Kimco Realty Corp (KIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • R-Pharm:製薬・医療:M&Aディール及び事業提携情報
    Summary R-Pharm is a pharmaceutical company that manufactures and markets therapeutic drugs. The company offers drugs in areas of oncology, hematology, cardiology, immunology, and antibacterial and anti-viral diseases. It offers solutions on treatment of HIV-infection, organ transplantation, dissemi …
  • Carl Zeiss Meditec AG (AFX):企業の財務・戦略的SWOT分析
    Carl Zeiss Meditec AG (AFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Riot Blockchain Inc (RIOT):企業の財務・戦略的SWOT分析
    Riot Blockchain Inc (RIOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Take-Two Interactive Software, Inc. (TTWO):企業の財務・戦略的SWOT分析
    Take-Two Interactive Software, Inc. (TTWO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Ocean Bio-Chem Inc (OBCI):企業の財務・戦略的SWOT分析
    Summary Ocean Bio-Chem Inc (OBCI) is a chemical manufacturing company that manufactures and markets maintenance and appearance products. The company's products include star brite products, performacide products, star tron products, and odor star products, among others. Its star tron products compris …
  • Aldevron LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aldevron LLC (Aldevron) is a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services. The company develops and manufactures plasmid deoxyribonucleic acid (Plasmid DNA), proteins and antibodies for research, preclinical and clinical applications serv …
  • Materialise NV (MTLS):企業の財務・戦略的SWOT分析
    Materialise NV (MTLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Jitsubo Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jitsubo Co Ltd (Jitsubo), a subsidiary of Sosei Group Corp, is a biotechnology company that develops, manufactures and commercializes peptide therapeutics. The company’s molecular hiving technology modifies the polysaccharide and sugar chain peptide sequence. Its Molecular Hiving technology …
  • Kohler Co:企業の戦略的SWOT分析
    Kohler Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • A2B Australia Limited
    A2B Australia Limited - Strategy, SWOT and Corporate Finance Report Summary A2B Australia Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • John Keells Hotels Plc
    John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆